ImageneBio, Inc. Common Stock

IMANASDAQUSD
5.54 USD
0.05 (0.89%)🟢LIVE (AS OF 09:49 AM EDT)
🟢Market: OPEN

Shares of ImageneBio, Inc. Common Stock (IMA) are trading at $5.54. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, IMA appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jul 24, 2026.

Open?$5.60
High?$5.60
Low?$5.35
Prev. Close?$5.59
Volume?206
Avg. Volume?11.6K
VWAP?$5.60
Rel. Volume?0.02x
Bid / Ask
Bid?$4.47 × 100
Ask?$6.50 × 100
Spread?$2.03
Midpoint?$5.48
Valuation & Ratios
Market Cap?63.1M
Shares Out?11.3M
Float?9.0M
Float %?79.7%
P/E Ratio?N/A
P/B Ratio?0.51
EPS?-$4.07
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Employees
17
Market Cap
63.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2025-07-28
Address
12526 HIGH BLUFF DRIVE
SAN DIEGO, CA 92130
Phone: 857-343-8292
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?4.38%Low
Short Interest?393.7K
Days to Cover?59.1
Free Float9.0M
Avg Daily Volume6.7K
Settlement Date2026-07-15
Financial Health
Current Ratio?18.39Strong
Quick Ratio?18.39Strong
Cash Ratio?11.46Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
97
0.51CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
Peers
100
S&P
97
0.2CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-37.2%WEAK
ROA?
S&P
3
-33.6%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-12997663
Fundamentals ratios updated end of day